Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
Figure 2
Laboratory markers before and after vaccination in advanced pancreatic cancer patients undergoing PPV with or without JTT. Laboratory markers were compared between before and after the first cycle of 6 vaccinations in the PPV plus JTT group and the PPV alone group by the paired Wilcoxon signed-rank test. The levels of hemoglobin (a), lymphocyte counts (b), albumin (c), and IL-6 (d) in peripheral blood before and after vaccination are shown. The results are represented by box-and-whiskers graphs. The box plots show median and interquartile range. The whiskers go down to the lowest value and up to the highest value.
